These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28504647)

  • 1. Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies.
    Nayar U; Sadek J; Reichel J; Hernandez-Hopkins D; Akar G; Barelli PJ; Sahai MA; Zhou H; Totonchy J; Jayabalan D; Niesvizky R; Guasparri I; Hassane D; Liu Y; Sei S; Shoemaker RH; Warren JD; Elemento O; Kaye KM; Cesarman E
    J Clin Invest; 2017 Jun; 127(6):2066-2080. PubMed ID: 28504647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma.
    Goto H; Kojima Y; Matsuda K; Kariya R; Taura M; Kuwahara K; Nagai H; Katano H; Okada S
    Eur J Cancer; 2014 Jul; 50(10):1836-1846. PubMed ID: 24726056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma.
    Dai L; Lin Z; Qiao J; Chen Y; Flemington EK; Qin Z
    Oncogene; 2017 Aug; 36(35):5068-5074. PubMed ID: 28459467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antitumor effects of methyl-β-cyclodextrin against primary effusion lymphoma via the depletion of cholesterol from lipid rafts.
    Gotoh K; Kariya R; Alam MM; Matsuda K; Hattori S; Maeda Y; Motoyama K; Kojima A; Arima H; Okada S
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):285-9. PubMed ID: 25446086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of the synthetic retinoid ST1926 on primary effusion lymphoma in vitro and in vivo models.
    Karam L; Houshaymi B; Abdel-Samad R; Jaafar M; Halloum I; Pisano C; Neipel F; Darwiche N; Abou Merhi R
    Oncol Rep; 2018 Feb; 39(2):721-730. PubMed ID: 29207182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphoma.
    Kojima Y; Hayakawa F; Morishita T; Sugimoto K; Minamikawa Y; Iwase M; Yamamoto H; Hirano D; Imoto N; Shimada K; Okada S; Kiyoi H
    Pharmacol Res; 2017 Jun; 120():242-251. PubMed ID: 28396094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathway.
    Kariya R; Taura M; Suzu S; Kai H; Katano H; Okada S
    Cancer Lett; 2014 Jan; 342(1):52-9. PubMed ID: 24012878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma.
    Caro-Vegas C; Bailey A; Bigi R; Damania B; Dittmer DP
    mBio; 2019 Feb; 10(1):. PubMed ID: 30782662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells.
    He M; Tan B; Vasan K; Yuan H; Cheng F; Ramos da Silva S; Lu C; Gao SJ
    J Pathol; 2017 Jul; 242(3):309-321. PubMed ID: 28393364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas.
    Bhatt AP; Bhende PM; Sin SH; Roy D; Dittmer DP; Damania B
    Blood; 2010 Jun; 115(22):4455-63. PubMed ID: 20299510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway.
    Takahashi-Makise N; Suzu S; Hiyoshi M; Ohsugi T; Katano H; Umezawa K; Okada S
    Int J Cancer; 2009 Sep; 125(6):1464-72. PubMed ID: 19521981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.
    Lan K; Murakami M; Bajaj B; Kaul R; He Z; Gan R; Feldman M; Robertson ES
    Cancer Biol Ther; 2009 Nov; 8(22):2136-43. PubMed ID: 19783901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-κB pathway.
    Goto H; Kariya R; Shimamoto M; Kudo E; Taura M; Katano H; Okada S
    Cancer Sci; 2012 Apr; 103(4):775-81. PubMed ID: 22320346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma.
    Chen J; Goyal N; Dai L; Lin Z; Del Valle L; Zabaleta J; Liu J; Post SR; Foroozesh M; Qin Z
    Blood; 2020 Nov; 136(19):2175-2187. PubMed ID: 32518949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma.
    Bhatt S; Ashlock BM; Toomey NL; Diaz LA; Mesri EA; Lossos IS; Ramos JC
    J Clin Invest; 2013 Jun; 123(6):2616-28. PubMed ID: 23635777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid liposomes inhibit the growth of primary effusion lymphoma in vitro and in vivo.
    Towata T; Komizu Y; Suzu S; Matsumoto Y; Ueoka R; Okada S
    Leuk Res; 2010 Jul; 34(7):906-11. PubMed ID: 20074798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient inhibition of NF-kappaB by DHMEQ induces cell death of primary effusion lymphoma without HHV-8 reactivation.
    Dabaghmanesh N; Matsubara A; Miyake A; Nakano K; Ishida T; Katano H; Horie R; Umezawa K; Watanabe T
    Cancer Sci; 2009 Apr; 100(4):737-46. PubMed ID: 19469019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome inhibitor MG-132 mediated expression of p27Kip1 via S-phase kinase protein 2 degradation induces cell cycle coupled apoptosis in primary effusion lymphoma cells.
    Hussain AR; Ahmed M; Ahmed SO; Al-Thari S; Khan AS; Razack S; Platanias LC; Al-Kuraya KS; Uddin S
    Leuk Lymphoma; 2009 Jul; 50(7):1204-13. PubMed ID: 19557642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer activities of parthenolide in primary effusion lymphoma preclinical models.
    Karam L; Abou Staiteieh S; Chaaban R; Hayar B; Ismail B; Neipel F; Darwiche N; Abou Merhi R
    Mol Carcinog; 2021 Aug; 60(8):567-581. PubMed ID: 34101920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.